Extracorporeal Shockwave Therapy (ESWT): Mechanism, Indications, and Outcomes

Extracorporeal Shockwave Therapy (ESWT) delivers high-energy acoustic waves to targeted tissues via a handheld applicator. Originally developed for kidney stones (lithotripsy), it's now a well-established, non-invasive treatment for chronic tendinopathies and other musculoskeletal conditions. The therapy stimulates biological healing rather than merely masking symptoms.

Mechanism of Action

• Mechanotransduction: Shockwaves create microtrauma and cavitation, triggering cellular signaling cascades.
• Neovascularization: Upregulates VEGF, eNOS → new capillary formation.
• Tissue regeneration: Stimulates tenocyte proliferation, collagen synthesis, mesenchymal stem cell recruitment.
• Anti-inflammatory: Modulates cytokine profile (↓ TNF-α, IL-1β; ↑ IL-10).
• Pain modulation: Gate control, substance P reduction, nerve ending desensitization.
• Calcific deposit resorption: Mechanical disruption + phagocytic removal (calcific tendinopathy).

FDA-Cleared Indications (Strongest Evidence)

• Plantar fasciitis (chronic, >6 months)
• Achilles tendinopathy (mid-portion, insertional)
• Calcific tendinitis of the shoulder
• Lateral epicondylitis (tennis elbow)
• Medial epicondylitis (golfer's elbow)
• Proximal hamstring tendinopathy
• Greater trochanteric pain syndrome (gluteal tendinopathy/bursitis)

Other Evidence-Supported Uses

• Patellar tendinopathy, rotator cuff tendinopathy (non-calcific), medial tibial stress syndrome, non-union fractures (adjunct), myofascial pain syndrome, spasticity reduction (neurologic).

Treatment Protocol

• Sessions: Typically 3-6, spaced 1 week apart.
• Energy flux density: 0.1-0.4 mJ/mm² (focused) or 0.1-0.5 mJ/mm² (radial).
• Impulses: 1500-3000 per session.
• Anesthesia: Usually none; topical lidocaine if needed. Focused ESWT more painful.

Focused vs. Radial Shockwaves

Parameter	Focused ESWT	Radial ESWT
Wave generation	Electrohydraulic, electromagnetic, piezoelectric	Ballistic (compressed air)
Energy peak	High (100+ MPa)	Lower (10-20 MPa)
Penetration depth	Deep (up to 12 cm), precise focus	Superficial (3-4 cm), divergent
Pain	More intense	Better tolerated
Best for	Deep tendons, calcific deposits, bone	Superficial tendons, myofascial, larger areas

Side Effects & Contraindications

• Common (transient): Erythema, bruising, swelling, pain during/after treatment.
• Rare: Nerve injury, tendon rupture (if overtreated), stress fracture.
• Contraindications: Pregnancy (over treatment area), malignancy, infection, coagulopathy/anticoagulation, open growth plates (focused), pacemaker (focused near chest), recent steroid injection (<6-12 wks).

Outcomes & Expectations

• Success rates: 65-85% for FDA-cleared indications at 3-6 months.
• Maximal benefit often at 12 weeks post-treatment.
• Not a quick fix — biological healing takes time.
• Combines synergistically with eccentric loading rehab.

ESWT is a valuable option for chronic tendinopathies failing conservative care. Proper patient selection, dosing, and integration with rehabilitation optimize outcomes.